Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Agree Realty, Raises Price Target to $77

Morgan Stanley analyst Ronald Kamdem maintains Agree Realty (NYSE:ADC) with a Overweight and raises the price target from $75 to $77.
byBenzinga Newsdesk
July 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Ronald Kamdem maintains Agree Realty (NYSE:ADC) with a Overweight and raises the price target from $75 to $77.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

MangoRx Introduces “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate And Pregnenolone For Treatment Of Low Testosterone And Male Hormone Imbalances; Sold Exclusively On MangoRx’s Website On A Subscription Basis At A Price Of $199…

By Benzinga Newsdesk
June 4, 8:01 AM
MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testosterone Replacement Therapy (TRT)Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) --

MGRX